{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:43:06Z","timestamp":1771551786699,"version":"3.50.1"},"reference-count":166,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The post-COVID condition (PCC) is a pathology stemming from COVID-19, and studying its pathophysiology, diagnosis, and treatment is crucial. Neuroinflammation causes the most common manifestations of this disease including headaches, fatigue, insomnia, depression, anxiety, among others. Currently, there are no specific management proposals; however, given that the inflammatory component involves cytokines and free radicals, these conditions must be treated to reduce the current symptoms and provide neuroprotection to reduce the risk of a long-term neurodegenerative disease. It has been shown that cannabis has compounds with immunomodulatory and antioxidant functions in other pathologies. Therefore, exploring this approach could provide a viable therapeutic option for PCC, which is the purpose of this review. This review involved an exhaustive search in specialized databases including PubMed, PubChem, ProQuest, EBSCO, Scopus, Science Direct, Web of Science, and Clinical Trials. Phytocannabinoids, including cannabidiol (CBD), cannabigerol (CBG), and Delta-9-tetrahydrocannabinol (THC), exhibit significant antioxidative and anti-inflammatory properties and have been shown to be an effective treatment for neuroinflammatory conditions. These compounds could be promising adjuvants for PCC alone or in combination with other antioxidants or therapies. PCC presents significant challenges to neurological health, and neuroinflammation and oxidative stress play central roles in its pathogenesis. Antioxidant therapy and cannabinoid-based approaches represent promising areas of research and treatment for mitigating adverse effects, but further studies are needed.<\/jats:p>","DOI":"10.3390\/ijms25073805","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:11:09Z","timestamp":1712229069000},"page":"3805","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-3440","authenticated-orcid":false,"given":"Noemi","family":"C\u00e1rdenas-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Laboratorio de Neurociencias, Instituto Nacional de Pediatr\u00eda, Mexico City 04530, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-4613","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ignacio-Mej\u00eda","sequence":"additional","affiliation":[{"name":"Laboratorio de Medicina Traslacional, Escuela Militar de Graduados de Sanidad, UDEFA, Mexico City 11200, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-5265","authenticated-orcid":false,"given":"Jose","family":"Correa-Basurto","sequence":"additional","affiliation":[{"name":"Laboratorio de Dise\u00f1o y Desarrollo de Nuevos F\u00e1rmacos e Innovaci\u00f3n Biotecnol\u00f3gica, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional, Mexico City 11340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Carrasco-Vargas","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de la Escuela Militar de Graduados de Sanidad, UDEFA, Mexico City 11200, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2518-2803","authenticated-orcid":false,"given":"Marco Antonio","family":"Vargas-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Subdirecci\u00f3n de Investigaci\u00f3n, Escuela Militar de Graduados en Sanidad, UDEFA, Mexico City 11200, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Exal Manuel","family":"Albores-M\u00e9ndez","sequence":"additional","affiliation":[{"name":"Subdirecci\u00f3n de Investigaci\u00f3n, Escuela Militar de Graduados en Sanidad, UDEFA, Mexico City 11200, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo David","family":"Mayen-Quinto","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda Molecular, Escuela Militar de Graduados en Sanidad, Mexico City 11200, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reynita","family":"De La Paz-Valente","sequence":"additional","affiliation":[{"name":"Laboratorio de Medicina Traslacional Aplicada a Neurociencias, Enfermedades Cr\u00f3nicas y Emergentes, Escuela superior de Medicina, Instituto Polit\u00e9cnico Nacional, Mexico City 11340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-2621","authenticated-orcid":false,"given":"Cindy","family":"Bandala","sequence":"additional","affiliation":[{"name":"Laboratorio de Medicina Traslacional Aplicada a Neurociencias, Enfermedades Cr\u00f3nicas y Emergentes, Escuela superior de Medicina, Instituto Polit\u00e9cnico Nacional, Mexico City 11340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/NNR.0000000000000565","article-title":"Post-COVID-19 syndrome","volume":"71","author":"Pierce","year":"2022","journal-title":"Nurs. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"204062232210768","DOI":"10.1177\/20406223221076890","article-title":"Neurological manifestations of the persistent COVID syndrome: A narrative review","volume":"13","author":"Stefanou","year":"2022","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"m3026","DOI":"10.1136\/bmj.m3026","article-title":"Management of post-acute COVID-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/23744235.2020.1772992","article-title":"Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection","volume":"52","author":"Levinson","year":"2020","journal-title":"Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gain, C., Song, S., Angtuaco, T., Satta, S., and Kelesidis, T. (2023). The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1111930"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Georgieva, E., Ananiev, J., Yovchev, Y., Arabadzhiev, G., Abrashev, H., Abrasheva, D., Atanasov, V., Kostandieva, R., Mitev, M., and Petkova-Parlapanska, K. (2023). COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914876"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Akanchise, T., and Angelova, A. (2023). Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants, 12.","DOI":"10.3390\/antiox12020393"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Akanchise, T., and Angelova, A. (2023). Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051562"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104551","DOI":"10.1016\/j.mvr.2023.104551","article-title":"Altered tissue oxygenation in patients with post COVID-19 syndrome","volume":"148","author":"Teschler","year":"2023","journal-title":"Microvasc. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Herder, V., Dee, K., Wojtus, J.K., Epifano, I., Goldfarb, D., Rozario, C., Gu, Q., Da Silva Filipe, A., Nomikou, K., and Nichols, J. (2021). Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses. PLoS Biol., 19.","DOI":"10.1371\/journal.pbio.3001065"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41380-022-01836-9","article-title":"Chronic post-viral fatigue and affective symptoms of prolonged COVID are associated with oxidative damage, decreased antioxidant defenses, and inflammation: A proof of concept and mechanism study","volume":"28","author":"Almulla","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"989717","DOI":"10.3389\/fphar.2022.989717","article-title":"Cannabidiol for neurodegenerative disorders: A comprehensive review","volume":"13","author":"Bhunia","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1039\/D3OB00383C","article-title":"Bioactivity of the cannabigerol cannabinoid and its analogues\u2014The role of 3-dimensional conformation","volume":"21","author":"Salha","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e2315","DOI":"10.1002\/rmv.2315","article-title":"Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies","volume":"32","author":"Yong","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s15010-021-01696-5","article-title":"Long COVID: Current definition","volume":"50","year":"2022","journal-title":"Infection"},{"key":"ref_16","unstructured":"(2023, November 27). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18. (NICE Guideline, No. 188), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567261\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(22)00169-2","article-title":"A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: An international Delphi consensus study","volume":"10","author":"Munblit","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: A systematic review and meta-analysis","volume":"11","author":"Perelman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(22)01385-X","article-title":"Long COVID: Which symptoms can be attributed to SARS-CoV-2 infection?","volume":"400","author":"Brightling","year":"2022","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.21307\/ane-2021-008","article-title":"Putative mechanism of neurological damage in COVID-19 infection","volume":"81","author":"Bandala","year":"2021","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: A comprehensive review","volume":"54","author":"Chalon","year":"2022","journal-title":"Ann. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100484","DOI":"10.1016\/j.eclinm.2020.100484","article-title":"Cerebral Micro-Structural Changes in COVID-19 Patients\u2014An MRI-based 3-month Follow-up Study","volume":"25","author":"Lu","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e147329","DOI":"10.1172\/JCI147329","article-title":"Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological man-ifestations","volume":"131","author":"Qin","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"110164","DOI":"10.1016\/j.ejrad.2022.110164","article-title":"Long-COVID diagnosis: From diagnostic to advanced AI-driven models","volume":"148","author":"Cau","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas-Rodr\u00edguez, N., Bandala, C., Vanoye-Carlo, A., Ignacio-Mej\u00eda, I., G\u00f3mez-Manzo, S., Hern\u00e1ndez-Cruz, E.Y., Pedraza-Chaverri, J., Carmona-Aparicio, L., and Hern\u00e1ndez-Ochoa, B. (2021). Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19. Antioxidants, 10.","DOI":"10.3390\/antiox10060971"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s10072-020-04694-x","article-title":"Headache and pleocytosis in CSF associated with COVID-19: Case report","volume":"41","author":"Palmeira","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_32","first-page":"1561","article-title":"Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: A systematic review of current literature","volume":"268","author":"Montemurro","year":"2020","journal-title":"J. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Leng, A., Shah, M., Ahmad, S.A., Premraj, L., Wildi, K., Li Bassi, G., Pardo, C.A., Choi, A., and Cho, S.M. (2023). Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells, 12.","DOI":"10.3390\/cells12050816"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1221266","DOI":"10.3389\/fneur.2023.1221266","article-title":"Reactive gliosis and neuroinflammation: Prime suspects in the pathophysiology of post-acute neuroCOVID-19 syndrome","volume":"14","author":"Saucier","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Robinson-Agramonte, M.L.A., S\u00e1nchez, T.S., Garc\u00eda, E.N., Barrera, O.R.S., and Siniscalco, D. (2023). COVID-19 and the Nervous System from a Cuban Experience. Behav. Sci., 13.","DOI":"10.3390\/bs13090776"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e073923","DOI":"10.1136\/bmj-2022-073923","article-title":"Pathophysiology, diagnosis, and management of neuroinflammation in COVID-19","volume":"382","author":"Brown","year":"2023","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/neurolint15030052","article-title":"Long COVID, the Brain, Nerves, and Cognitive Function","volume":"15","author":"Reiss","year":"2023","journal-title":"Neurol. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-023-02612-x","article-title":"Vagus nerve inflammation contributes to dysautonomia in COVID-19","volume":"146","author":"Woo","year":"2023","journal-title":"Acta Neuropathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/joim.13720","article-title":"Cognitive dysfunction in post-COVID-19 condition: Mechanisms, management, and rehabilitation","volume":"294","author":"Borg","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1239182","DOI":"10.3389\/fneur.2023.1239182","article-title":"Cognitive impairment after long COVID-19: Current evidence and perspectives","volume":"14","author":"Li","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1216457","DOI":"10.3389\/fimmu.2023.1216457","article-title":"COVID, complement, and the brain","volume":"14","author":"Vlaicu","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00011-023-01722-2","article-title":"Long-COVID fatigue is not predicted by pre-pandemic plasma IL-6 levels in mild COVID-19","volume":"72","author":"Freidin","year":"2023","journal-title":"Inflamm. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12967-023-04515-7","article-title":"Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?","volume":"21","author":"Paiva","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Meyerson, W.U., and Hoyle, R.H. (2023). Pre-pandemic activity on a myalgic encephalomyelitis\/chronic fatigue syndrome support forum is highly associated with later activity on a long COVID support forum for a variety of reasons: A mixed methods study. PLoS ONE, 18.","DOI":"10.1101\/2023.06.30.23292087"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/03007995.2023.2242244","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and COVID-19: Is there a connection?","volume":"39","author":"AlMuhaissen","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2967\/jnumed.121.262128","article-title":"Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients","volume":"62","author":"Blazhenets","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00259-021-05215-4","article-title":"18F-FDG brain PET hypometabolism in patients with long COVID","volume":"48","author":"Guedj","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"745789","DOI":"10.3389\/fmed.2021.745789","article-title":"Neuroinflammation and its impact on the pathogenesis of COVID-19","volume":"8","author":"Almutairi","year":"2021","journal-title":"Front. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: Symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sivandzade, F., Alqahtani, F., and Cucullo, L. (2020). Traumatic brain injury and blood-brain barrier (BBB): Underlying pathophysiological mechanisms and the influence of smoking as a premorbid condition. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082721"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12035-020-02093-z","article-title":"Effects of antimalarial drugs on neuroinflammation: Potential use for treatment of neurological complications related to COVID-19","volume":"58","author":"Ong","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zabetakis, I., Lordan, R., Norton, C., and Tsoupras, A. (2020). COVID-19: The inflammation link and the role of nutrition in potential mitigation. Nutrients, 12.","DOI":"10.3390\/nu12051466"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s42399-020-00522-7","article-title":"SARS-CoV-2, an Underestimated Pathogen of the Nervous System","volume":"2","author":"Jakhmola","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Gebo, K.A., Heath, S.L., Fukuta, Y., Zhu, X., Baksh, S., Abraham, A.G., Habtehyimer, F., Shade, D., Ruff, J., and Ram, M. (2023). CSSC-004 Consortium. Early antibody treatment, inflammation, and risk of post-COVID conditions. mBio, 14.","DOI":"10.1128\/mbio.00618-23"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: A post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Tan, P.H., Ji, J., Hsing, C.H., Tan, R., and Ji, R.R. (2022). Emerging functions of type I interferons in neuroinflammation, neurological diseases, and long COVID. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214394"},{"key":"ref_58","first-page":"1543","article-title":"COVID-19 and Oxidative Stress","volume":"85","author":"Chernyak","year":"2020","journal-title":"Biochemistry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5589089","DOI":"10.1155\/2022\/5589089","article-title":"Mechanisms related to oxidative stress in SARS-CoV-2 infections","volume":"2022","author":"Wieczfinska","year":"2022","journal-title":"Oxid Med. Cell Longev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/acschemneuro.1c00666","article-title":"Interactions between SARS-CoV-2 N-Protein and \u03b1-Synuclein Accelerate Amyloid Formation","volume":"13","author":"Semerdzhiev","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Melrose, J., and Smith, M.M. (2022). Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline. Front. Biosci., 14.","DOI":"10.31083\/j.fbe1404027"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2174\/1568026622666220401140737","article-title":"Vitamin D and its Possible Relationship to Neuroprotection in COVID-19: Evidence in the Literature","volume":"22","author":"Bandala","year":"2022","journal-title":"Curr. Top Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Chen, T.B., Chang, C.M., Yang, C.C., Tsai, I.J., Wei, C.Y., Yang, H.W., and Yang, C.P. (2023). Neuroimmunological Effect of Vitamin D on Neuropsychiatric Long COVID Syndrome: A Review. Nutrients, 15.","DOI":"10.3390\/nu15173802"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Pirro, M., Ferri, L., Piccioni, L., Bellucci, A.M., Bartolucci, F., Russo, A., Piga, A., Ciaramaglia, P.L., Lucangeli, M., and Russo, A.M. (2023). What Is the Role of Palmitoylethanolamide Co-Ultramicronized with Luteolin on the Symptomatology Reported by Patients Suffering from Long COVID? A Retrospective Analysis Performed by a Group of General Practitioners in a Real-Life Setting. Nutrients, 15.","DOI":"10.3390\/nu15173701"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Di Stadio, A., Bernitsas, E., La Mantia, I., Brenner, M.J., Ralli, M., Vaira, L.A., Colizza, A., Cavaliere, C., Laudani, M., and Frohman, T.C. (2023). Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?. Life, 13.","DOI":"10.3390\/life13010226"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1007\/s00405-023-08085-8","article-title":"Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: A blinded controlled multicenter randomized trial","volume":"280","author":"Gallina","year":"2023","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clinph.2022.10.017","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome","volume":"145","author":"Versace","year":"2023","journal-title":"Clin. Neurophysiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-022-03488-3","article-title":"Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) and Long-COVID fatigue patients: A non-randomized controlled clinical trial","volume":"20","author":"Cash","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/biof.1726","article-title":"Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue","volume":"47","author":"Theoharides","year":"2021","journal-title":"Biofactors"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13287-022-02900-5","article-title":"Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: A pilot study","volume":"13","author":"Zhu","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.arcmed.2022.03.002","article-title":"Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID-19: A Randomized Controlled Trial","volume":"53","author":"Nashibi","year":"2022","journal-title":"Arch. Med. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Raghavan, K., Dedeepiya, V.D., Suryaprakash, V., Rao, K.S., Ikewaki, N., Sonoda, T., Levy, G.A., Iwasaki, M., Senthilkumar, R., and Preethy, S. (2022). Beneficial effects of novel aureobasidium pullulans strains produced beta-1, 3-1, 6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study. Biomed. Pharmacother., 145.","DOI":"10.1016\/j.biopha.2021.112243"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1161849","DOI":"10.3389\/fimmu.2023.1161849","article-title":"The value of Interferon \u03b2 in multiple sclerosis and novel opportunities for its anti-viral activity: A narrative literature review","volume":"14","author":"Bellucci","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Pintori, N., Caria, F., De Luca, M.A., and Miliano, C. (2023). THC and CBD: Villain versus Hero? Insights into Adolescent Exposure. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065251"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/can.2020.0105","article-title":"The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies","volume":"6","author":"Henshaw","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7196\/SAMJ.2020.v110i3.14403","article-title":"Medical cannabis: What practitioners need to know","volume":"110","author":"Blockman","year":"2020","journal-title":"S. Afr. Med. J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Krzy\u017cewska, A., Baranowska-Kuczko, M., Jastrz\u0105b, A., Kasacka, I., and Koz\u0142owska, H. (2022). Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension. Molecules, 27.","DOI":"10.3390\/molecules27103327"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: A review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorganic. Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/apha.12474","article-title":"Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells","volume":"214","author":"Braitch","year":"2015","journal-title":"Acta Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.00712.x","article-title":"Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells","volume":"160","author":"Rajesh","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_81","first-page":"607","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2012.09.053","article-title":"Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis","volume":"697","author":"Barichello","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"591","DOI":"10.21873\/invivo.13117","article-title":"Anti-inflammatory Effect of a Combination of Cannabidiol and Morinda citrifolia Extract on Lipopolysaccharide-stimulated RAW264 Macrophages","volume":"37","author":"Tanikawa","year":"2023","journal-title":"In Vivo"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","article-title":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","volume":"74","author":"Sonego","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3389\/fimmu.2018.01782","article-title":"Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells","volume":"9","author":"Elliott","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_87","first-page":"299","article-title":"Cannabidiol Protects Striatal Neurons by Attenuating Endoplasmic Reticulum Stress","volume":"8","author":"Patel","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4236\/pp.2015.62010","article-title":"Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol","volume":"6","author":"Gallily","year":"2015","journal-title":"Pharmacol. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Giuliano, C., Francavilla, M., Ongari, G., Petese, A., Ghezzi, C., Rossini, N., Blandini, F., and Cerri, S. (2021). Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168920"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2016.03.005","article-title":"Cannabidiol and epilepsy: Rationale and therapeutic potential","volume":"107","author":"Leo","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11481-021-10023-6","article-title":"Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis","volume":"17","author":"Dopkins","year":"2022","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Meyer, E., Rieder, P., Gobbo, D., Candido, G., Scheller, A., de Oliveira, R.M.W., and Kirchhoff, F. (2022). Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112886"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/j.pain.0000000000001896","article-title":"A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain","volume":"161","author":"Verrico","year":"2020","journal-title":"Pain"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.intimp.2008.11.010","article-title":"Cannabidiol decreases bone resorption by inhibiting RANK\/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats","volume":"9","author":"Napimoga","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5935\/0103-507X.20150064","article-title":"Evaluation of the role of the cannabidiol system in an animal model of ischemia\/reperfusion kidney injury","volume":"27","author":"Soares","year":"2015","journal-title":"Rev. Bras. Ter. Intensiv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","article-title":"Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e13756","DOI":"10.1111\/nmo.13756","article-title":"Effects of O-1602 and CBD on TNBS-induced colonic disturbances","volume":"32","author":"Wei","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","article-title":"Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis","volume":"87","author":"Borrelli","year":"2009","journal-title":"J. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPA.0b013e318259f6f0","article-title":"Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice","volume":"42","author":"Li","year":"2013","journal-title":"Pancreas"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The Endocannabinoid System and its Modulation by Phytocannabinoids","volume":"12","author":"Piscitelli","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu-and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.phrs.2016.07.008","article-title":"Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats","volume":"111","author":"Zamberletti","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/ptr.7710","article-title":"Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation","volume":"37","author":"Borgonetti","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Gugliandolo, A., Blando, S., Salamone, S., Caprioglio, D., Pollastro, F., Mazzon, E., and Chiricosta, L. (2023). \u03948-THC Protects against Amyloid Beta Toxicity Modulating ER Stress In Vitro: A Transcriptomic Analysis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076598"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02190083","article-title":"Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial","volume":"240","author":"Maurer","year":"1990","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0031-1297940","article-title":"The major plant-derived cannabinoid \u0394(9)-tetrahydrocannabinol promotes hypertrophy and macrophage infiltration in adipose tissue","volume":"44","author":"Wong","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/0960327119886037","article-title":"Systemic administration with tetrahydrocannabinol causes retinal damage in BALB\/c mice","volume":"39","author":"Zhang","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1007\/s11033-022-07996-9","article-title":"Anti-inflammatory potential of delta-9-tetrahydrocannabinol in hyperinsulinemia: An experimental study","volume":"49","author":"Yazici","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbi.2019.07.028","article-title":"Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome","volume":"82","author":"Busbee","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2019.06.033","article-title":"Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis","volume":"516","author":"Zhou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.119.263319","article-title":"Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain","volume":"373","author":"Britch","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3389\/fimmu.2019.01921","article-title":"Combination of Cannabinoids, \u03949- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways","volume":"10","author":"Miranda","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3336516","DOI":"10.1155\/2022\/3336516","article-title":"Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives","volume":"2022","author":"Calapai","year":"2022","journal-title":"Evid Based Complement. Altern. Med."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Perez, E., Fernandez, J.R., Fitzgerald, C., Rouzard, K., Tamura, M., and Savile, C. (2022). In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties. Molecules, 27.","DOI":"10.3390\/molecules27020491"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Fleisher-Berkovich, S., Ventura, Y., Amoyal, M., Dahan, A., Feinshtein, V., Alfahel, L., Israelson, A., Bernstein, N., Gorelick, J., and Ben-Shabat, S. (2023). Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules, 13.","DOI":"10.3390\/biom13020376"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11481-012-9399-3","article-title":"A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis","volume":"7","author":"Granja","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40035-019-0148-x","article-title":"Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration","volume":"8","author":"Aguareles","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"29789","DOI":"10.1038\/srep29789","article-title":"VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington\u2019s disease","volume":"6","author":"Navarrete","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-018-1060-5","article-title":"Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson\u2019s disease: Possible involvement of different binding sites at the PPAR\u03b3 receptor","volume":"15","author":"Burgaz","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Burgaz, S., Garc\u00eda, C., G\u00f3mez-Ca\u00f1as, M., Mu\u00f1oz, E., and Fern\u00e1ndez-Ruiz, J. (2019). Development of An Oral Treatment with the PPAR-\u03b3-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson\u2019s Disease. Molecules, 24.","DOI":"10.3390\/molecules24152702"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Mammana, S., Cavalli, E., Gugliandolo, A., Silvestro, S., Pollastro, F., Bramanti, P., and Mazzon, E. (2019). Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol. Medicina, 55.","DOI":"10.3390\/medicina55110747"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jns.2017.06.017","article-title":"Sativex\u00ae effects on promoter methylation and on CNR1\/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients","volume":"379","author":"Santoro","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.cgh.2023.07.008","article-title":"A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis","volume":"21","author":"Zheng","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ibd\/izz017","article-title":"Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial","volume":"25","author":"Couch","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jid.2022.03.029","article-title":"Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial","volume":"142","author":"Werth","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/jocd.14263","article-title":"Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study","volume":"21","author":"Gao","year":"2022","journal-title":"J. Cosmet Dermatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2020.09.008","article-title":"Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis","volume":"20","author":"Chmiel","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/art.41294","article-title":"Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults with Systemic Sclerosis","volume":"72","author":"Spiera","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/ptr.6651","article-title":"Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults","volume":"34","author":"Hobbs","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1111\/bph.15157","article-title":"The potential of cannabidiol in the COVID-19 pandemic","volume":"177","author":"Esposito","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"eabi6110","DOI":"10.1126\/sciadv.abi6110","article-title":"Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses","volume":"8","author":"Nguyen","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/can.2022.0135","article-title":"A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome","volume":"9","author":"Young","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_135","unstructured":"National Library of Medicine (U.S.) (2023, November 27). Feasibility of Cannabidiol for the Treatment of Long COVID, Available online: https:\/\/clinicaltrials.gov."},{"key":"ref_136","unstructured":"National Library of Medicine (U.S.) (2023, November 27). Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID, Available online: https:\/\/clinicaltrials.gov."},{"key":"ref_137","unstructured":"National Library of Medicine (U.S.) (2023, November 27). (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC, Available online: https:\/\/clinicaltrials.gov."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Niloy, N., Hediyal, T.A., Vichitra, C., Sonali, S., Chidambaram, S.B., Gorantla, V.R., and Mahalakshmi, A.M. (2023). Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review. Biomolecules, 13.","DOI":"10.3390\/biom13010162"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Aguiar, A.F.L., Campos, R.M.P., Isaac, A.R., Paes-Colli, Y., Carvalho, V.M., Sampaio, L.S., and de Melo Reis, R.A. (2023). Long-Term Treatment with Cannabidiol-Enriched Cannabis Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411775"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.26502\/acmcr.96550456","article-title":"Rehabilitating Effect of Marijuana on Post-COVID-19 Pain Syndrome","volume":"6","author":"Weinbroum","year":"2022","journal-title":"Arch. Clin. Med. Case Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1080\/07391102.2021.1905556","article-title":"Insilico inquest reveals the efficacy of Cannabis in the treatment of post-COVID-19 related neurodegeneration","volume":"40","author":"Sarkar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"153396","DOI":"10.1016\/j.phymed.2020.153396","article-title":"Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: Can it be a potential therapeutic option for COVID-19?","volume":"85","author":"Palit","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_145","unstructured":"Patel, V.B., and Preedy, V.R. (2023). Neurobiology and Physiology of the Endocannabinoid, Academic Press. [1st ed.]."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/bph.15461","article-title":"Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19","volume":"179","author":"Cinar","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s11064-023-03912-0","article-title":"Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog","volume":"48","author":"Kazama","year":"2023","journal-title":"Neurochem. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1189\/jlb.1206738","article-title":"Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells","volume":"81","author":"Giudice","year":"2007","journal-title":"J. Leukoc Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.1401844","article-title":"Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor \u03b3 in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo","volume":"194","author":"Hegde","year":"2015","journal-title":"J. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbi.2023.05.008","article-title":"Cannabidiol alleviates neuroinflammation and attenuates neuropathic pain via targeting FKBP5","volume":"111","author":"Wang","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s10020-022-00528-y","article-title":"Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis\/chronic fatigue syndrome patients","volume":"28","author":"Sasso","year":"2022","journal-title":"Mol. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","article-title":"Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: Pro-apoptotic effects and underlying mechanisms","volume":"168","author":"Ligresti","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ercegovac, M., Asanin, M., Savic-Radojevic, A., Ranin, J., Matic, M., Djukic, T., Coric, V., Jerotic, D., Todorovic, N., and Milosevic, I. (2022). Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants, 11.","DOI":"10.3390\/antiox11050954"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42238-023-00190-z","article-title":"Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: In silico and in vivo studies of the involvement of Akt","volume":"5","author":"Akinloye","year":"2023","journal-title":"J. Cannabis Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?","volume":"59","author":"Theoharides","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"687783","DOI":"10.3389\/fcvm.2021.687783","article-title":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity","volume":"8","author":"Raghavan","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Kim, E.S., Jeon, M.T., Kim, K.S., Lee, S., Kim, S., and Kim, D.G. (2021). Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells. Viruses, 13.","DOI":"10.3390\/v13102021"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41593-020-00771-8","article-title":"The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice","volume":"24","author":"Rhea","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Paladino, L., Vitale, A.M., Caruso Bavisotto, C., Conway de Macario, E., Cappello, F., Macario, A.J.L., and Gammazza, A.M. (2020). The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113518"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/acs.jnatprod.1c00946","article-title":"Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants","volume":"85","author":"Muchiri","year":"2022","journal-title":"J. Nat. Prod."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Binetti, J., Real, M., Renzulli, M., Bertran, L., Riesco, D., Perpi\u00f1an, C., Mohedano, A., Segundo, R.S., Ortiz, M., and Porras, J.A. (2023). Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue. Viruses, 15.","DOI":"10.3390\/v15071452"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12967-023-04229-w","article-title":"The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome","volume":"21","author":"Ghali","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e28373","DOI":"10.1002\/jmv.28373","article-title":"Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome","volume":"95","author":"Parker","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12979-023-00341-z","article-title":"Aged brain and neuroimmune responses to COVID-19: Post-acute sequelae and modulatory effects of behavioral and nutritional interventions","volume":"20","year":"2023","journal-title":"Immun. Ageing"},{"key":"ref_166","first-page":"5871","article-title":"Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy\u2014Preliminary results on 100 patients","volume":"25","author":"Tirelli","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/3805\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:20:30Z","timestamp":1760106030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/3805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":166,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["ijms25073805"],"URL":"https:\/\/doi.org\/10.3390\/ijms25073805","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}